Aspirin decreases the risk of hepatocellular cancer in at-risk patients. Nierengarten MB. Cancer 2022;128:214-215.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nierengarten MB. Aspirin decreases the risk of hepatocellular cancer in at-risk patients. Cancer 2022;128:214-215.
PMID: 34990011